
Emcure Pharmaceuticals Limited has informed the Exchange regarding a press release dated April 04, 2025, titled "Emcure s European subsidiary Tillomed acquires strategic pharma portfolio from Manx".
Filed with NSE ·

Emcure Pharmaceuticals Limited has informed the Exchange regarding a press release dated April 04, 2025, titled "Emcure s European subsidiary Tillomed acquires strategic pharma portfolio from Manx".
6ix hasn’t read this filing yet.
Emcure Pharmaceuticals Limited on 6ix
Follow Emcure Pharmaceuticals into a list and get an email when it puts out news.
Follow Emcure Pharmaceuticals